If the war on drugs were one of his businesses, said Sir Richard Branson, the renowned British magnate, philanthropist and activist, it would have been shut down within a year. “It hasn’t worked at all, ever, but governments continue to ignore the facts, creating untold misery. Drug use isn’t a criminal problem. It’s a health problem.”
Scientists at UC San Diego, MIT and Harvard University have engineered “topological plexcitons,” energy-carrying particles that could help make possible the design of new kinds of solar cells and miniaturized optical circuitry.
Excitement was palpable at UC San Diego’s inaugural Triton Entrepreneur Night as student entrepreneurs, alumni, staff, and community supporters gathered for demos and presentations from the latest crop of student-driven innovations.
Students and researchers at all stages of their academic careers went head-to-head recently, competing for $100k in prizes at the 10th annual UC San Diego Entrepreneur Challenge.
Calit2 is an early partner and will be a user of KnuEdge's new computing architecture inspired by an earlier processor developed in Calit2's Circuits Labs at UC San Diego. The technology could dramatically accelerate machine learning, Big Data analytics and other computations.
To better understand the pathogenic bacteria Staphylococcus aureus and develop more effective treatments, University of California San Diego researchers examined the Staph “pan-genome” — the genomes of 64 different strains that differ in where they live, the types of hosts they infect and their antibiotic resistance profiles. This effort, published June 6 by PNAS, places all Staph genes into one of two categories: the core genome or the dispensable genome.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
